Screener
Rockwell Medical RMTI Q3 2026 earnings
Reported November 12, 2026 · Before market open
Revenue$19.1MBeat by $902.0K
EPS-$0.59Miss by $0.41
Revenue estimate$18.2M
EPS estimate-$0.18
“Our third quarter 2026 net sales grew 20% year-over-year, reflecting strong customer adoption and market validation of our products. Our team's commitment to quality and reliable customer service continues to set us apart. We are excited to build on this momentum with our recently announced equity and asset purchase agreement with Vantive, a transformational step that we believe will significantly expand our portfolio and global reach. As we celebrate our 30th anniversary, we are well-positioned to drive innovation and capitalize on emerging growth opportunities.”
Next report
Date not yet announcedVersus estimates
Revenue
Diluted EPS
FAQ
- When did Rockwell Medical report Q3 2026 earnings?
- Rockwell Medical (RMTI) reported Q3 2026 earnings on November 12, 2026 before market open.
- What were Rockwell Medical's Q3 2026 revenue and EPS?
- Rockwell Medical reported revenue of $19.1M and eps of $-0.59 for Q3 2026.
- Did Rockwell Medical beat estimates in Q3 2026?
- Revenue beat the consensus estimate of $18.2M by $902.0K. EPS missed the consensus estimate of $-0.18 by $0.41.
- How did Rockwell Medical's Q3 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 20.1% from $15.9M a year earlier and eps declined 1080.0% from $-0.05.
- Where can I find Rockwell Medical's Q3 2026 SEC filings?
- You can read the 8-K earnings release (0001628280-26-073052) and the 10-Q periodic report (0001628280-26-073086) directly on SEC EDGAR. The filing index links above go to sec.gov.
